These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11274800)

  • 1. Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection.
    Medina J; Salvadó A; del Pozo A
    Int J Pharm; 2001 Mar; 216(1-2):1-8. PubMed ID: 11274800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorazepam stability in parenteral solutions for continuous intravenous administration.
    Hoey LL; Vance-Bryan K; Clarens DM; Wright DH; Konstantinides FN; Guay DR
    Ann Pharmacother; 1996 Apr; 30(4):343-6. PubMed ID: 8729885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion.
    Deng Y; Zhong G; Wang Y; Wang N; Yu Q; Yu X
    Int J Pharm; 2019 Nov; 571():118717. PubMed ID: 31610279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and properties of a stable intravenous lorazepam emulsion.
    Yalin M; Oner F; Oner L; Hincal AA
    J Clin Pharm Ther; 1997 Feb; 22(1):39-44. PubMed ID: 9292401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics.
    Yao J; Hou L; Zhou JP; Zhang ZQ; Sun L
    Pharmazie; 2009 Oct; 64(10):642-7. PubMed ID: 19947165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion.
    Tian L; He H; Tang X
    J Pharm Sci; 2007 Jul; 96(7):1719-28. PubMed ID: 17503537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion.
    Shi S; Chen H; Cui Y; Tang X
    Int J Pharm; 2009 May; 373(1-2):147-55. PubMed ID: 19429300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of lorazepam microemulsions for parenteral delivery.
    Kale AA; Patravale VB
    AAPS PharmSciTech; 2008; 9(3):966-71. PubMed ID: 18720016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulating and stability of benzodiazepines in a new lipid emulsion formulation.
    Jumaa M; Müller BW
    Pharmazie; 2002 Nov; 57(11):740-3. PubMed ID: 12611276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging.
    Driscoll DF; Ling PR; Bistrian BR
    JPEN J Parenter Enteral Nutr; 2007; 31(2):148-53. PubMed ID: 17308256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.
    Sila-on W; Vardhanabhuti N; Ongpipattanakul B; Kulvanich P
    AAPS PharmSciTech; 2008; 9(2):684-92. PubMed ID: 18496755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Liposyn II fat emulsion in total nutrient admixtures.
    Sayeed FA; Johnson HW; Sukumaran KB; Raihle JA; Mowles DL; Stelmach HA; Majors KR
    Am J Hosp Pharm; 1986 May; 43(5):1230-5. PubMed ID: 3087165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of lorazepam after simulated administration from glass and polyvinyl chloride containers.
    Mancano MA; Boullata JI; Gelone SP; Zitterman RE; Borenstein MR
    Am J Health Syst Pharm; 1995 Oct; 52(20):2213-6. PubMed ID: 8564593
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous infusion of undiluted lorazepam injection.
    Johnson TJ; Voss G
    Am J Health Syst Pharm; 2002 Jan; 59(1):78-9. PubMed ID: 11813472
    [No Abstract]   [Full Text] [Related]  

  • 16. Propylene glycol toxicity occurs during low-dose infusions of lorazepam.
    Arbour R
    Crit Care Med; 2003 Feb; 31(2):664-5; author reply 665. PubMed ID: 12576996
    [No Abstract]   [Full Text] [Related]  

  • 17. Droplet-size distribution and stability of commercial injectable lipid emulsions containing fish oil.
    Gallegos C; Valencia C; Partal P; Franco JM; Maglio O; Abrahamsson M; Brito-de la Fuente E
    Am J Health Syst Pharm; 2012 Aug; 69(15):1332-5. PubMed ID: 22821793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droplet-size distribution and stability of lipid injectable emulsions.
    Gallegos C; Partal P; Franco JM
    Am J Health Syst Pharm; 2009 Jan; 66(2):162-6. PubMed ID: 19139481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid vehicles for the parenteral administration of drugs (1): emulsions].
    Bermejo Vicedo T; Hidalgo Correas FJ; Carrasco JM
    Nutr Hosp; 1996; 11(1):7-16. PubMed ID: 8704021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical stability of teniposide in aqueous and parenteral lipid emulsions.
    Wang J; Cui Y; Tang X
    Drug Dev Ind Pharm; 2009 Apr; 35(4):508-13. PubMed ID: 18991092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.